PacBio to Participate in TD Cowen's 45th Annual Health Care Conference
PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, has announced its participation in TD Cowen's 45th Annual Health Care Conference. The company's management will deliver a presentation on Tuesday, March 4, 2025, at 3:10 PM ET (12:10 PM PT) in Boston, MA.
Interested parties can access a live webcast of the presentation through PacBio's investors page at investor.pacificbiosciences.com. The webcast recording will remain available for viewing for a minimum of 30 days after the event.
PacBio (NASDAQ: PACB), un importante sviluppatore di soluzioni di sequenziamento di alta qualità e alta precisione, ha annunciato la sua partecipazione alla 45ª Conferenza Annuale sulla Salute di TD Cowen. La direzione dell'azienda presenterà un intervento martedì 4 marzo 2025, alle 15:10 ET (12:10 PT) a Boston, MA.
Le parti interessate possono accedere a una diretta streaming della presentazione tramite la pagina degli investitori di PacBio all'indirizzo investor.pacificbiosciences.com. La registrazione della diretta rimarrà disponibile per la visione per un minimo di 30 giorni dopo l'evento.
PacBio (NASDAQ: PACB), un desarrollador líder de soluciones de secuenciación de alta calidad y alta precisión, ha anunciado su participación en la 45ª Conferencia Anual de Atención Médica de TD Cowen. La dirección de la empresa realizará una presentación el martes 4 de marzo de 2025, a las 3:10 PM ET (12:10 PM PT) en Boston, MA.
Las partes interesadas pueden acceder a una transmisión en vivo de la presentación a través de la página de inversores de PacBio en investor.pacificbiosciences.com. La grabación de la transmisión estará disponible para su visualización durante un mínimo de 30 días después del evento.
PacBio (NASDAQ: PACB), 고품질 및 고정밀 시퀀싱 솔루션의 선두 개발업체가 TD Cowen의 제45회 연례 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 2025년 3월 4일 화요일 오후 3시 10분 ET (오후 12시 10분 PT)에 매사추세츠주 보스턴에서 발표를 진행할 예정입니다.
관심 있는 분들은 investor.pacificbiosciences.com의 PacBio 투자자 페이지를 통해 발표의 라이브 웹캐스트에 접속할 수 있습니다. 웹캐스트 녹화는 이벤트 후 최소 30일 동안 시청 가능합니다.
PacBio (NASDAQ: PACB), un développeur de solutions de séquençage de haute qualité et de haute précision, a annoncé sa participation à la 45e Conférence Annuelle sur les Soins de Santé de TD Cowen. La direction de l'entreprise présentera une communication le mardi 4 mars 2025, à 15h10 ET (12h10 PT) à Boston, MA.
Les parties intéressées peuvent accéder à un webinaire en direct de la présentation via la page des investisseurs de PacBio à l'adresse investor.pacificbiosciences.com. L'enregistrement du webinaire restera disponible à la visualisation pendant un minimum de 30 jours après l'événement.
PacBio (NASDAQ: PACB), ein führender Entwickler von hochqualitativen und hochpräzisen Sequenzierungslösungen, hat seine Teilnahme an der 45. jährlichen Gesundheitskonferenz von TD Cowen bekannt gegeben. Das Management des Unternehmens wird am Dienstag, den 4. März 2025, um 15:10 Uhr ET (12:10 Uhr PT) in Boston, MA, eine Präsentation halten.
Interessierte Parteien können über die Investoren-Seite von PacBio unter investor.pacificbiosciences.com auf einen Live-Webcast der Präsentation zugreifen. Die Aufzeichnung des Webcasts bleibt mindestens 30 Tage nach der Veranstaltung verfügbar.
- None.
- None.
MENLO PARK, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at TD Cowen's 45th Annual Health Care Conference on Tuesday, March 4, 2025, at 3:10 PM ET (12:10 PM PT) in Boston, MA.
A live webcast of the event can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days following the event.
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies stem from two highly differentiated core technologies focused on accuracy, quality, and completeness, which include our HiFi long-read sequencing and our SBB® short-read sequencing technologies. Our products address solutions across a broad set of research applications, including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
Todd Friedman
ir@pacb.com
Media:
pr@pacb.com
FAQ
When is PacBio (PACB) presenting at TD Cowen's Health Care Conference 2025?
How can investors watch PacBio's (PACB) presentation at the TD Cowen conference?
How long will PacBio's (PACB) TD Cowen conference presentation replay be available?
Where is the 2025 TD Cowen Healthcare Conference featuring PACB being held?
